FDA Section 5 \u2022 cited verbatim

Sucralfate - Warnings and Precautions

The following warnings and precautions are taken directly from the US FDA-approved drug label for Sucralfate. This is the same information dispensing pharmacists read.

WARNINGS Fatal complications, including pulmonary and cerebral emboli have occurred with inappropriate intravenous administration of Sucralfate Oral Suspension.

Administer Sucralfate Oral Suspension only by the oral route.

Do not administer intravenously.

Applies to YOU?

Some warnings apply only to specific age groups, health conditions, or other medicines. Ask GoDavaii AI to filter which of these 3+ warnings apply to your profile.

Ask Health AI \u2192